D. Western Therapeutics Institute, Inc. (FRA:6DW)
Germany flag Germany · Delayed Price · Currency is EUR
0.5050
0.00 (0.00%)
Last updated: Feb 23, 2026, 8:12 AM CET

FRA:6DW Ratios and Metrics

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Feb '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
302851295748
Market Cap Growth
-9.70%-44.02%73.82%-48.77%17.18%-27.68%
Enterprise Value
242250214837
Last Close Price
0.510.471.120.811.751.55
PS Ratio
14.1213.4417.4710.5817.8515.32
PB Ratio
3.813.6311.223.544.283.12
P/TBV Ratio
3.823.6311.943.804.623.45
EV/Sales Ratio
11.1510.5017.257.7615.0811.55
EV/FCF Ratio
-8.78-----
Debt / Equity Ratio
0.420.421.090.690.520.17
Net Debt / Equity Ratio
-0.77-0.77-0.45-0.77-0.73-0.78
Net Debt / EBITDA Ratio
1.931.930.281.315.2612.55
Net Debt / FCF Ratio
2.232.230.251.643.778.96
Asset Turnover
0.200.200.230.160.170.16
Inventory Turnover
0.410.410.500.430.340.29
Quick Ratio
8.858.859.4810.2311.8710.54
Current Ratio
9.919.9111.1711.0212.6011.20
Return on Equity (ROE)
-58.27%-58.27%-128.23%-52.51%-22.59%-7.62%
Return on Assets (ROA)
-20.18%-20.18%-37.42%-18.72%-7.06%-4.13%
Return on Invested Capital (ROIC)
-188.52%-168.71%-345.71%-199.50%-64.83%-45.56%
Return on Capital Employed (ROCE)
-31.50%-31.50%-78.70%-36.60%-11.10%-7.60%
Earnings Yield
-11.55%-12.14%-15.68%-17.93%-5.36%-2.33%
FCF Yield
-9.07%-9.53%-15.90%-13.20%-4.54%-2.81%
Buyback Yield / Dilution
-36.48%-36.48%-10.51%-7.22%-1.04%-7.96%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.